Genetic factors account for up to 80% of the liability for schizophrenia and bipolar disorder. Genome-wide association studies (GWAS) have successfully identified several single nucleotide polymorphisms (SNPs) and genes associated with increased risk for both disorders. Single SNP analyses alone do not address the overall genomic or polygenic architecture of psychiatric disorders as the amount of phenotypic variation explained by each GWAS-supported SNP is small whereas the number of SNPs/regions underlying risk for illness is thought to be very large. The polygenic risk score models the aggregate effect of alleles associated with disease status present in each individual and allows us to utilise the power of large GWAS to be applied robustly in small samples. Here we make the case that risk prediction, intervention and personalised medicine can only benefit with the inclusion of polygenic risk scores in imaging genetics research.
AlyMWiklundFXuJ. (2011) Polygenic risk score improves prostate cancer risk prediction: Results from the Stockholm-1 Cohort Study. Eur Urol60: 21–28.
3.
AthanasiuLMattingsdalMKahlerAK. (2010) Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort. J Psychiatr Res44: 748–753.
4.
ChatterjeeNWheelerBSampsonJ. (2013) Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studies. Nat Genet45: 400–405.
5.
ChenDTJiangXAkulaN. (2013) Genome-wide association study meta-analysis of European and Asian-ancestry samples identifies three novel loci associated with bipolar disorder. Mol Psychiatry18: 195–205.
6.
CichonSMühleisenTWDegenhardtFA. (2011) Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet88: 372–381.
7.
CraddockNSklarP (2009) Genetics of bipolar disorder: Successful start to a long journey. Trends Genet25: 99–105.
8.
Cross-Disorder Group of the Psychiatric Genomics Consortium; Genetic Risk Outcome of Psychosis (GROUP) Consortium (2013) Identification of risk loci with shared effects on five major psychiatric disorders: A genome-wide analysis. Lancet381: 1371–1379.
9.
DemirkanAPenninxBWHekK. (2011) Genetic risk profiles for depression and anxiety in adult and elderly cohorts. Mol Psychiatry16: 773–783.
10.
DerksEMVorstmanJASRipkeS. (2012) Investigation of the genetic association between quantitative Measures of psychosis and schizophrenia: A polygenic risk score analysis. PLoS One7: e37852.
11.
DimaDJogiaJCollierD. (2013) Independent modulation of engagement and connectivity of the facial network during affect processing by CACNA1C and ANK3 risk genes for bipolar disorder. JAMA Psychiatry70: 1303–1311.
12.
DudbridgeF (2013) Power and predictive accuracy of polygenic risk scores. PLoS Genet9: e1003348.
13.
ErkSMeyer-LindenbergASchmiererP. (2013) Hippocampal and frontolimbic function as intermediate phenotype for psychosis: Evidence from healthy relatives and a common risk variant in CACNA1C. Biol Psychiatry76: 466–475.
14.
FerreiraMAO’DonovanMCMengYA. (2008) Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet40: 1056–1058.
15.
FrankeBVasquezAAVeltmanJA. (2010) Genetic variation in CACNA1C, a gene associated with bipolar disorder, influences brainstem rather than gray matter volume in healthy individuals. Biol Psychiatry68: 586–588.
FritscheLGChenWSchuM. (2013) Seven new loci associated with age-related macular degeneration. Nat Genet45: 433–439.
18.
GreenEKGrozevaDFortyL. (2013) Association at SYNE1 in both bipolar disorder and recurrent major depression. Mol Psychiatry18: 614–617.
19.
HalldenSSjogrenMHedbladB. (2013) Smoking and obesity associated BDNF gene variance predicts total and cardiovascular mortality in smokers. Heart99: 949–953.
20.
HennekensCHHennekensARHollarD. (2005) Schizophrenia and increased risks of cardiovascular disease. Am Heart J150: 1115–1121.
21.
HolmesAJLeePHHollinsheadMO. (2012) Individual differences in amygdala-medial prefrontal anatomy link negative affect, impaired social functioning, and polygenic depression risk. J Neurosci32: 18087–18100.
22.
JogiaJRubertoGLelli-ChiesaG. (2011) The impact of the CACNA1C gene polymorphism on frontolimbic function in bipolar disorder. Mol Psychiatry16: 1070–1071.
23.
KatoMSerrettiA (2010) Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol Psychiatry15: 473–500.
24.
KemptonMJRubertoGVassosE. (2009) Effects of the CACNA1C risk allele for bipolar disorder on cerebral gray matter volume in healthy individuals. Am J Psychiatry166: 1413–1414.
25.
KimHLimSWKimS. (2006) Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression. JAMA296: 1609–1618.
26.
KirchheinerJFuhrUBrockmollerJ (2005) Pharmacogenetics-based therapeutic recommendations–ready for clinical practice?Nat Rev Drug Discov4: 639–647.
27.
KleinRJZeissCChewEY. (2005) Complement factor H polymorphism in age-related macular degeneration. Science308: 385–389.
28.
LanderESLintonLMBirrenB. (2001) Initial sequencing and analysis of the human genome. Nature409: 860–921.
29.
LandriganCPParryGJBonesCB. (2010) Temporal trends in rates of patient harm resulting from medical care. N Engl J Med363: 2124–2134.
30.
LazarouJPomeranzBHCoreyPN (1998) Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA279: 1200–1205.
31.
LichtensteinPYipBHBjorkC. (2009) Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: A population-based study. Lancet373: 234–239.
32.
LucianoMHuffmanJEArias-VásquezA. (2012) Genome-wide association uncovers shared genetic effects among personality traits and mood states. Am J Med Genet B Neuropsychiatr Genet159: 684–695.
33.
McGuffinPRijsdijkFAndrewM. (2003) The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry60: 497–502.
34.
MiddeldorpCMde MoorMHMcGrathLM. (2011) The genetic association between personality and major depression or bipolar disorder. A polygenic score analysis using genome-wide association data. Transl Psychiatry1: e50.
35.
MrazekDALermanC (2011) Facilitating clinical implementation of pharmacogenomics. JAMA306: 304–305.
36.
O’DonovanMCCraddockNNortonN. (2008) Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet40: 1053–1055.
37.
PaulusFMBedenbenderJKrachS. (2014) Association of rs1006737 in CACNA1C with alterations in prefrontal activation and fronto-hippocampal connectivity. Hum Brain Mapp35: 1190–1200.
38.
PerrierEPompeiFRubertoG. (2011) Initial evidence for the role of CACNA1C on subcortical brain morphology in patients with bipolar disorder. Eur Psychiatry26: 135–137.
39.
PetersonREMaesHHHolmansP. (2011) Genetic risk sum score comprised of common polygenic variation is associated with body mass index. Hum Genet129: 221–230.
40.
PhillipsDPBarkerGE (2010) A July spike in fatal medication errors: A possible effect of new medical residents. J Gen Intern Med25: 774–779.
41.
PurcellSMWrayNRStoneJL. (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature460: 748–752.
42.
RaduaJSurguladzeSAMarshallN. (2013) The impact of CACNA1C allelic variation on effective connectivity during emotional processing in bipolar disorder. Mol Psychiatry18: 526–527.
RasettiRSambataroFChenQ. (2011) Altered cortical network dynamics: A potential intermediate phenotype for schizophrenia and association with ZNF804A. Arch Gen Psychiatry68: 1207–1217.
RipkeSO’DushlaineCChambertK. (2013) Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nature Genet45: 1150–1159.
47.
RipkeSSandersARKendlerKS. (2011) Genome-wide association study identifies five new schizophrenia loci. Nat Genet43: 969–976.
48.
SchulzeTGDetera-WadleighSDAkulaN. (2009) Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder. Mol Psychiatry14: 487–491.
49.
ScottLJMugliaPKongXQ. (2009) Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry. Proc Natl Acad Sci U S A106: 7501–7506.
50.
ShiJLevinsonDFDuanJ. (2009) Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature460: 753–757.
51.
SklarPRipkeSScottLJ. (2011) Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet43: 977–983.
52.
SklarPSmollerJWFanJ. (2008) Whole-genome association study of bipolar disorder. Mol Psychiatry13: 558–569.
53.
SmithENBlossCSBadnerJA. (2009) Genome-wide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry14: 755–763.
54.
SpeliotesEKWillerCJBerndtSI. (2010) Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet42: 937–948.
55.
StefanssonHOphoffRASteinbergS. (2009) Common variants conferring risk of schizophrenia. Nature460: 744–747.
56.
SullivanPFKendlerKSNealeMC (2003) Schizophrenia as a complex trait: Evidence from a meta-analysis of twin studies. Arch Gen Psychiatry60: 1187–1192.
57.
TanHYChenAGKolachanaB. (2012) Effective connectivity of AKT1-mediated dopaminergic working memory networks and pharmacogenetics of anti-dopaminergic treatment. Brain135: 1436–1445.
58.
TanseyKEGuipponiMPerroudN. (2012) Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: A genome-wide analysis of individual-level data and a meta-analysis. PLoS Med9: e1001326.
59.
TesliMKoefoedPAthanasiuL. (2011) Association analysis of ANK3 gene variants in Nordic bipolar disorder and schizophrenia case-control samples. Am J Med Genet B Neuropsychiatr Genet156B: 969–974.
60.
TesliMSkatunKCOusdalOT. (2013) CACNA1C risk variant and amygdala activity in bipolar disorder, schizophrenia and healthy controls. PLoS One8: e56970.
61.
van ScheltingaAFTBakkerSCvan HarenNEM. (2013) Schizophrenia genetic variants are not associated with intelligence. Psychol Med43: 2563–2570.
62.
VorstmanJASAnneyRJLDerksEM. (2013) No evidence that common genetic risk variation is shared between schizophrenia and autism. Am J Med Genet B Neuropsychiatr Genet162: 55–60.
63.
WaltonETurnerJGollubRL. (2013) Cumulative genetic risk and prefrontal activity in patients with schizophrenia. Schizophr Bull39: 703–711.
64.
WangFMcIntoshAMHeY. (2011) The association of genetic variation in CACNA1C with structure and function of a frontotemporal system. Bipolar Disord13: 696–700.
65.
WhalleyHCPapmeyerMSprootenE. (2012) The influence of polygenic risk for bipolar disorder on neural activation assessed using fMRI. Transl Psychiatry2: e130.
66.
WhalleyHCSprootenEHackettS. (2013) Polygenic risk and white matter integrity in individuals at high risk of mood disorder. Biol Psychiatry74: 280–286.
